デフォルト表紙
市場調査レポート
商品コード
1387785

3D細胞培養技術の世界市場レポート 2024年

3D Cell Culture Technologies Global Market Report 2024

出版日: 受注後更新 | 発行: The Business Research Company | ページ情報: 英文 175 Pages | 納期: 2~10営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報(例:国別セグメント)の追加などの対応が可能です。  詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=160.11円
3D細胞培養技術の世界市場レポート 2024年
出版日: 受注後更新
発行: The Business Research Company
ページ情報: 英文 175 Pages
納期: 2~10営業日
  • 全表示
  • 概要
  • 目次
概要

2023年の3D細胞培養技術市場で最大の地域は北米。西欧は3D細胞培養技術市場で2番目に大きい地域です。3D細胞培養技術市場レポートの対象地域は、アジア太平洋、西欧、東欧、北米、南米、中東・アフリカです。

目次

第1章 エグゼクティブサマリー

第2章 3D細胞培養技術市場の特徴

第3章 3D細胞培養技術市場の動向と戦略

第4章 3D細胞培養技術市場-マクロ経済シナリオ

  • 高インフレが3D細胞培養技術市場に与える影響
  • ウクライナ・ロシア戦争が3D細胞培養技術市場に与える影響
  • COVID-19による3D細胞培養技術市場への影響

第5章 世界の3D細胞培養技術市場規模と成長

  • 世界の3D細胞培養技術市場の促進要因と抑制要因
    • 市場の促進要因
    • 市場の抑制要因
  • 世界の3D細胞培養技術の市場規模実績と成長、2018~2023年
  • 世界の3D細胞培養技術の市場規模と成長予測、2023年から2028年、2033年

第6章 3D細胞培養技術市場セグメンテーション

  • 世界の3D細胞培養技術市場、タイプ別セグメンテーション、実績および予測、2018~2023年、2023~2028年、2033年
  • 足場ベース
  • 非足場ベース
  • 3Dバイオリアクター
  • 世界の3D細胞培養技術市場、用途別セグメンテーション、実績および予測、2018~2023年、2023~2028年、2033年
  • がん研究
  • 幹細胞研究
  • 創薬
  • 再生医療
  • 世界の3D細胞培養技術市場、エンドユーザー別セグメンテーション、実績および予測、2018~2023年、2023~2028年、2033年
  • 調査および研究所
  • バイオテクノロジー企業と製薬会社
  • 病院と診断センター
  • その他のエンドユーザー

第7章 3D細胞培養技術市場の地域および国分析

  • 世界の3D細胞培養技術市場、地域別、実績および予測、2018~2023年、2023~2028年、2033年
  • 世界の3D細胞培養技術市場、国別、実績および予測、2018~2023年、2023~2028年、2033年

第8章 アジア太平洋の3D細胞培養技術市場

第9章 中国の3D細胞培養技術市場

第10章 インドの3D細胞培養技術市場

第11章 日本の3D細胞培養技術市場

第12章 オーストラリアの3D細胞培養技術市場

第13章 インドネシアの3D細胞培養技術市場

第14章 韓国の3D細胞培養技術市場

第15章 西欧の3D細胞培養技術市場

第16章 英国の3D細胞培養技術市場

第17章 ドイツの3D細胞培養技術市場

第18章 フランスの3D細胞培養技術市場

第19章 イタリアの3D細胞培養技術市場

第20章 スペインの3D細胞培養技術市場

第21章 東欧の3D細胞培養技術市場

第22章 ロシアの3D細胞培養技術市場

第23章 北米の3D細胞培養技術市場

第24章 米国の3D細胞培養技術市場

第25章 カナダの3D細胞培養技術市場

第26章 南米の3D細胞培養技術市場

第27章 ブラジルの3D細胞培養技術市場

第28章 中東の3D細胞培養技術市場

第29章 アフリカの3D細胞培養技術市場

第30章 3D細胞培養技術市場の競合情勢と企業プロファイル

  • 3D細胞培養技術市場の競合情勢
  • 3D細胞培養技術市場の企業プロファイル
    • Becton Dickinson and Company
    • Corning Incorporated
    • Eppendorf AG
    • GE Healthcare a division of General Electric Company
    • Merck KGaA

第31章 世界の3D細胞培養技術市場の競合ベンチマーキング

第32章 世界3D細胞培養技術市場競合ダッシュボード

第33章 3D細胞培養技術市場における主要な合併と買収

第34章 3D細胞培養技術市場の将来展望と可能性分析

第35章 付録

目次
Product Code: r9027

“3D Cell Culture Technologies Global Market Report 2024 ” from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on 3d cell culture technologies market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 50+ geographies.
  • Understand how the market has been affected by the COVID-19 and how it is responding as the impact of the virus abates.
  • Assess the Russia - Ukraine war's impact on agriculture, energy and mineral commodity supply and its direct and indirect impact on the market.
  • Measure the impact of high global inflation on market growth.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market shares.
  • Benchmark performance against key competitors.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 3-5 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for 3d cell culture technologies? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? “The 3d cell culture technologies market global report ” from The Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

  • The market characteristics section of the report defines and explains the market.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include:

The impact of sanctions, supply chain disruptions, and altered demand for goods and services due to the Russian Ukraine war, impacting various macro-economic factors and parameters in the Eastern European region and its subsequent effect on global markets.

The impact of higher inflation in many countries and the resulting spike in interest rates.

The continued but declining impact of COVID-19 on supply chains and consumption patterns.

  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

Markets Covered:

  • 1) By Type: Scaffold-based; Scaffold-free; 3D Bioreactors
  • 2) By Application: Cancer Research; Stem Cell Research; Drug Discovery; Regenerative Medicine
  • 3) By End Users: Research Laboratories and Institutes; Biotechnology and Pharmaceutical Companies; Hospitals and Diagnostic Centers; Other End Users
  • Subsegment: Hydrogels; Polymeric scaffolds; Micropatterned Surface Microplates; Hanging Drop Microplates; Spheroid Microplates; Microfluidic 3D Cell Culture; Magnetic Levitations & 3D Bioprinting
  • Companies Mentioned: Becton Dickinson and Company; Corning Incorporated; Eppendorf AG; GE Healthcare a division of General Electric Company; Merck KGaA
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
  • Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery format: PDF, Word and Excel Data Dashboard.

Executive Summary

Cell culture is a critical process in the production of safe viral vaccines. 3D cell culture represents an advanced in vitro technique where cells can thrive within an artificially engineered environment.

The primary categories of 3D cell culture technologies are scaffold-based, scaffold-free, and 3D bioreactors. 3D bioreactors, for instance, are specialized plastic cylinder chambers tailored for cultivating cells in a three-dimensional fashion. These technologies find application in various fields, including cancer research, stem cell research, drug discovery, and regenerative medicine. They are utilized by a wide range of users, including research laboratories, biotechnology and pharmaceutical companies, hospitals, diagnostic centers, and other institutions.

The 3D cell culture technologies market research report is one of a series of new reports from The Business Research Company that provides 3D cell culture technologies market statistics, including 3D cell culture technologies industry global market size, regional shares, competitors with a 3D cell culture technologies market share, detailed 3D cell culture technologies market segments, market trends and opportunities, and any further data you may need to thrive in the 3D cell culture technologies industry. This 3D cell culture technologies market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The 3d cell culture technologies market size has grown rapidly in recent years. It will grow from $2.85 billion in 2023 to $3.39 billion in 2024 at a compound annual growth rate (CAGR) of 19.0%. The growth observed in the historical period can be attributed to progress in the field of cell biology, advancements in drug development, the increasing prevalence of chronic diseases, and government funding support.

The 3d cell culture technologies market size is expected to see rapid growth in the next few years. It will grow to $6.94 billion in 2028 at a compound annual growth rate (CAGR) of 19.6%. The anticipated growth in the forecast period can be attributed to factors such as the expanding pharmaceutical industry, a surge in research and development activities, as well as growing environmental and ethical considerations. Notable trends expected during this period encompass personalized medicine, continuous technological advancements, the emergence of bioprinting, and the advancement of regenerative medicine.

The demand for organ transplantation is a key driver for the 3D Cell Culture Technologies Market. 3D cell culture plays a crucial role in creating three-dimensional structures that closely resemble tissues and organs, making it instrumental for successful organ transplantation. Furthermore, 3D cell structures offer the potential for tissue and organ regeneration and serve as a valuable tool for drug toxicity screening. For instance, in January 2023, data from the United Network for Organ Sharing (UNOS), a US-based non-profit organization, revealed that in 2022, the United States witnessed a 3.7% increase in organ transplants, with 42,887 procedures performed. A record-breaking 14,903 individuals became deceased organ donors in 2022, marking the twelfth consecutive year of growth and a 7.5% increase over 2021. This growth is partly attributed to the broadening of medical criteria for deceased organ donation based on positive clinical outcomes, leading to a higher proportion of donors from non-traditional eligibility categories. Notably, there was a nearly 14% increase in donations after circulatory death (DCD donors) in 2022 compared to 2021, and for the first time, there were more than 5,000 donors aged 50 or older in a single year, with 5,789 in total.

The anticipated growth of the 3D cell culture technologies market is largely attributed to the increasing momentum in drug discovery. Drug discovery involves the exploration of potential new medicinal compounds through a combination of computational, experimental, translational, and clinical models. Notably, 3D cell culture technologies are gaining significance in the realm of drug discovery due to their ability to provide more precise and dependable results. They enable microscale 3D cultures, offer higher predictive value for clinical outcomes, and eliminate the need for animal models. For example, as of January 2023, the Food and Drug Administration (FDA), a US federal agency under the Department of Health and Human Services, reported the approval of 37 new drugs and therapeutic biological products by the FDA's Centre for Drug Evaluation and Research (CDER) in the United States for various medical indications in 2022. This reaffirms the crucial role of 3D cell culture technologies in advancing drug discovery, making it a driving force behind the growth of the 3D cell culture technologies market.

The 3D Cell Culture technologies market is facing constraints due to the potential risk of cell contamination. Cell culture contamination, in this context, pertains to the presence of bacteria, molds, yeasts, viruses, and mycoplasma, which can have detrimental effects on the cell culture process. Contamination typically occurs due to improper handling of cells or a lack of appropriate care, ultimately affecting the regeneration process. A study conducted by Yale and Tufts University underscores the greater complexity of 3D cultures compared to their 2D counterparts. To accurately mimic tissue or organ structures, 3D cell cultures demand a highly controlled cellular environment. Consequently, the probability of cell culture contamination is relatively higher in the case of 3D cell cultures, posing a challenge for this market.

The current trend in the 3D Cell Culture market revolves around the adoption of cutting-edge technology. Several companies have embraced a notable advancement in this sector, namely the utilization of in vivo/in vitro environments. Traditional cell expansion and interactions in 2D in vitro models have limitations, but when compared to the 3D cell culture technique, the latter offers a more conducive environment for cell culture. The in vitro environment empowers researchers and medical professionals to carry out procedures within a controlled setting outside the living organism. This approach is gaining significant importance, particularly in the context of patient health monitoring. Notably, the FDA has granted approval for Biotek's 3D cell expansion system to be used as a medical device. Additionally, Biotek's Polycaprolactone (PCL), a biodegradable polyester material utilized in numerous FDA-approved implants and drug delivery devices, has also received FDA approval. This reflects the growing significance of advanced technology adoption in the 3D Cell Culture market.

Prominent players in the 3D Cell Culture Technologies market are strategically introducing innovative products, such as PODS-PeptiGels, to enhance their competitive position. PODS-PeptiGels represents a novel approach that combines two advanced cell culture technologies such as synthetic peptide hydrogels (PeptiGels) and a diverse array of sustained-release growth factors (PODS). This combination results in a reproducible and highly adaptable environment for 3D cell culture. For example, in April 2022, as reported by Cell Guidance Systems, a UK-based biotechnology company, a collaboration with Manchester BIOGEL led to the launch of PODS-PeptiGels for 3D cell culture. This ready-to-use kit empowers researchers to customize their approach to align with the objectives of their research. They can choose from a selection of over 70 growth factors and combine them with a wide variety of hydrogels, each offering specific mechanical and biomimetic properties. Manchester Biogel, another UK-based biotechnology company, specializes in the design and manufacturing of 3D synthetic peptide hydrogels. This strategic introduction of innovative products demonstrates a commitment to staying competitive in the 3D Cell Culture Technologies market.

In May 2021, the USA-based start-up CELLINK Group, specializing in the design and provision of technologies and services to advance biological research, successfully completed the acquisition of Visikol Corporation for a sum of $7.5 million. This strategic acquisition marked CELLINK's foray into the contract research market. Visikol Corporation, an American contract research services firm, is known for offering top-tier services in areas such as 3D cell culture, 3D tissue imaging, multiplex imaging, and digital pathology, catering primarily to the pharmaceutical and biotechnology sectors.

Major companies operating in the 3D cell culture technologies market include Becton Dickinson and Company, Corning Incorporated, Eppendorf AG, GE Healthcare a division of General Electric Company, Merck KGaA, Thermo Fisher Scientific Inc., Lonza Group AG, HiMedia Laboratories Pvt. Ltd., Agilent Technologies Inc., PromoCell GmbH, CellGenix GmbH, Greiner Bio-One International GmbH, Irvine Scientific Sales Company Inc., Cell Culture Company LLC, SeraCare Life Sciences Inc., American Type Culture Collection (ATCC), Miltenyi Biotec B.V. & Co. KG, AITbiotech Pte Ltd, Essen BioScience a Sartorius Company, Sigma-Aldrich, Bel-Art Products Inc., MilliporeSigma, Sumitomo Bakelite, EMD Millipore, Affymetrix Inc., VWR International llc., WHEATON IndustriesInc, Sartorius AG, CN Bio Innovations, Nortis Inc., Kiyatec, Nanofiber Solutions, Copner Biotech, Known Medicine, Synthecon Inc., 3D Biotek LLC, 3D Cell Culture Innovations LLC., 3D Matrix Inc., Allevi Inc., BioSpherix Ltd., Emulate Inc., MicroTissues Inc.

North America was the largest region in the 3D cell culture technologies market in 2023. Western Europe was the second largest region in the 3D cell culture technologies market. The regions covered in the 3d cell culture technologies market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

The countries covered in the 3d cell culture technologies market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Italy, Spain, Canada

The 3D cell culture technologies market consists of sales of 3D cell culture technologies such as microfluidics, hydrogels scaffolds, scaffold-free 3D cell culture techniques, spheroids, cube, spherical droplet, stacked plate, magnetic bead, organ-on-chips and other technologies. Values in this market are factory gate values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Table of Contents

1. Executive Summary

2. 3D Cell Culture Technologies Market Characteristics

3. 3D Cell Culture Technologies Market Trends And Strategies

4. 3D Cell Culture Technologies Market - Macro Economic Scenario

  • 4.1. Impact Of High Inflation On The Market
  • 4.2. Ukraine-Russia War Impact On The Market
  • 4.3. COVID-19 Impact On The Market

5. Global 3D Cell Culture Technologies Market Size and Growth

  • 5.1. Global 3D Cell Culture Technologies Market Drivers and Restraints
    • 5.1.1. Drivers Of The Market
    • 5.1.2. Restraints Of The Market
  • 5.2. Global 3D Cell Culture Technologies Historic Market Size and Growth, 2018 - 2023, Value ($ Billion)
  • 5.3. Global 3D Cell Culture Technologies Forecast Market Size and Growth, 2023 - 2028, 2033F, Value ($ Billion)

6. 3D Cell Culture Technologies Market Segmentation

  • 6.1. Global 3D Cell Culture Technologies Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Scaffold-Based
  • Scaffold-Free
  • 3D Bioreactors
  • 6.2. Global 3D Cell Culture Technologies Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Cancer Research
  • Stem Cell Research
  • Drug Discovery
  • Regenerative Medicine
  • 6.3. Global 3D Cell Culture Technologies Market, Segmentation By End Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Research Laboratories And Institutes
  • Biotechnology And Pharmaceutical Companies
  • Hospitals And Diagnostic Centers
  • Other End Users

7. 3D Cell Culture Technologies Market Regional And Country Analysis

  • 7.1. Global 3D Cell Culture Technologies Market, Split By Region, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 7.2. Global 3D Cell Culture Technologies Market, Split By Country, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

8. Asia-Pacific 3D Cell Culture Technologies Market

  • 8.1. Asia-Pacific 3D Cell Culture Technologies Market Overview
  • Region Information, Impact Of COVID-19, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 8.2. Asia-Pacific 3D Cell Culture Technologies Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 8.3. Asia-Pacific 3D Cell Culture Technologies Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 8.4. Asia-Pacific 3D Cell Culture Technologies Market, Segmentation By End Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

9. China 3D Cell Culture Technologies Market

  • 9.1. China 3D Cell Culture Technologies Market Overview
  • 9.2. China 3D Cell Culture Technologies Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
  • 9.3. China 3D Cell Culture Technologies Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
  • 9.4. China 3D Cell Culture Technologies Market, Segmentation By End Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion

10. India 3D Cell Culture Technologies Market

  • 10.1. India 3D Cell Culture Technologies Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 10.2. India 3D Cell Culture Technologies Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 10.3. India 3D Cell Culture Technologies Market, Segmentation By End Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

11. Japan 3D Cell Culture Technologies Market

  • 11.1. Japan 3D Cell Culture Technologies Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 11.2. Japan 3D Cell Culture Technologies Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 11.3. Japan 3D Cell Culture Technologies Market, Segmentation By End Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

12. Australia 3D Cell Culture Technologies Market

  • 12.1. Australia 3D Cell Culture Technologies Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 12.2. Australia 3D Cell Culture Technologies Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 12.3. Australia 3D Cell Culture Technologies Market, Segmentation By End Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

13. Indonesia 3D Cell Culture Technologies Market

  • 13.1. Indonesia 3D Cell Culture Technologies Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 13.2. Indonesia 3D Cell Culture Technologies Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 13.3. Indonesia 3D Cell Culture Technologies Market, Segmentation By End Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

14. South Korea 3D Cell Culture Technologies Market

  • 14.1. South Korea 3D Cell Culture Technologies Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 14.2. South Korea 3D Cell Culture Technologies Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 14.3. South Korea 3D Cell Culture Technologies Market, Segmentation By End Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

15. Western Europe 3D Cell Culture Technologies Market

  • 15.1. Western Europe 3D Cell Culture Technologies Market Overview
  • 15.2. Western Europe 3D Cell Culture Technologies Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 15.3. Western Europe 3D Cell Culture Technologies Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 15.4. Western Europe 3D Cell Culture Technologies Market, Segmentation By End Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

16. UK 3D Cell Culture Technologies Market

  • 16.1. UK 3D Cell Culture Technologies Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 16.2. UK 3D Cell Culture Technologies Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 16.3. UK 3D Cell Culture Technologies Market, Segmentation By End Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

17. Germany 3D Cell Culture Technologies Market

  • 17.1. Germany 3D Cell Culture Technologies Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 17.2. Germany 3D Cell Culture Technologies Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 17.3. Germany 3D Cell Culture Technologies Market, Segmentation By End Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

18. France 3D Cell Culture Technologies Market

  • 18.5. France 3D Cell Culture Technologies Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 18.6. France 3D Cell Culture Technologies Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 18.7. France 3D Cell Culture Technologies Market, Segmentation By End Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

19. Italy 3D Cell Culture Technologies Market

  • 19.9. Italy 3D Cell Culture Technologies Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 19.10. Italy 3D Cell Culture Technologies Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 19.11. Italy 3D Cell Culture Technologies Market, Segmentation By End Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

20. Spain 3D Cell Culture Technologies Market

  • 20.13. Spain 3D Cell Culture Technologies Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 20.14. Spain 3D Cell Culture Technologies Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 20.15. Spain 3D Cell Culture Technologies Market, Segmentation By End Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

21. Eastern Europe 3D Cell Culture Technologies Market

  • 21.1. Eastern Europe 3D Cell Culture Technologies Market Overview
  • 21.2. Eastern Europe 3D Cell Culture Technologies Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 21.3. Eastern Europe 3D Cell Culture Technologies Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 21.4. Eastern Europe 3D Cell Culture Technologies Market, Segmentation By End Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

22. Russia 3D Cell Culture Technologies Market

  • 22.1. Russia 3D Cell Culture Technologies Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 22.2. Russia 3D Cell Culture Technologies Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 22.3. Russia 3D Cell Culture Technologies Market, Segmentation By End Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

23. North America 3D Cell Culture Technologies Market

  • 23.1. North America 3D Cell Culture Technologies Market Overview
  • 23.2. North America 3D Cell Culture Technologies Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 23.3. North America 3D Cell Culture Technologies Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 23.4. North America 3D Cell Culture Technologies Market, Segmentation By End Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

24. USA 3D Cell Culture Technologies Market

  • 24.1. USA 3D Cell Culture Technologies Market Overview
  • 24.2. USA 3D Cell Culture Technologies Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 24.3. USA 3D Cell Culture Technologies Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 24.4. USA 3D Cell Culture Technologies Market, Segmentation By End Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

25. Canada 3D Cell Culture Technologies Market

  • 25.1. Canada 3D Cell Culture Technologies Market Overview
  • 25.2. Canada 3D Cell Culture Technologies Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 25.3. Canada 3D Cell Culture Technologies Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 25.4. Canada 3D Cell Culture Technologies Market, Segmentation By End Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

26. South America 3D Cell Culture Technologies Market

  • 26.1. South America 3D Cell Culture Technologies Market Overview
  • 26.2. South America 3D Cell Culture Technologies Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 26.3. South America 3D Cell Culture Technologies Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 26.4. South America 3D Cell Culture Technologies Market, Segmentation By End Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

27. Brazil 3D Cell Culture Technologies Market

  • 27.1. Brazil 3D Cell Culture Technologies Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 27.2. Brazil 3D Cell Culture Technologies Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 27.3. Brazil 3D Cell Culture Technologies Market, Segmentation By End Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

28. Middle East 3D Cell Culture Technologies Market

  • 28.1. Middle East 3D Cell Culture Technologies Market Overview
  • 28.2. Middle East 3D Cell Culture Technologies Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 28.3. Middle East 3D Cell Culture Technologies Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 28.4. Middle East 3D Cell Culture Technologies Market, Segmentation By End Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

29. Africa 3D Cell Culture Technologies Market

  • 29.1. Africa 3D Cell Culture Technologies Market Overview
  • 29.2. Africa 3D Cell Culture Technologies Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 29.3. Africa 3D Cell Culture Technologies Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 29.4. Africa 3D Cell Culture Technologies Market, Segmentation By End Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

30. 3D Cell Culture Technologies Market Competitive Landscape And Company Profiles

  • 30.1. 3D Cell Culture Technologies Market Competitive Landscape
  • 30.2. 3D Cell Culture Technologies Market Company Profiles
    • 30.2.1. Becton Dickinson and Company
      • 30.2.1.1. Overview
      • 30.2.1.2. Products and Services
      • 30.2.1.3. Strategy
      • 30.2.1.4. Financial Performance
    • 30.2.2. Corning Incorporated
      • 30.2.2.1. Overview
      • 30.2.2.2. Products and Services
      • 30.2.2.3. Strategy
      • 30.2.2.4. Financial Performance
    • 30.2.3. Eppendorf AG
      • 30.2.3.1. Overview
      • 30.2.3.2. Products and Services
      • 30.2.3.3. Strategy
      • 30.2.3.4. Financial Performance
    • 30.2.4. GE Healthcare a division of General Electric Company
      • 30.2.4.1. Overview
      • 30.2.4.2. Products and Services
      • 30.2.4.3. Strategy
      • 30.2.4.4. Financial Performance
    • 30.2.5. Merck KGaA
      • 30.2.5.1. Overview
      • 30.2.5.2. Products and Services
      • 30.2.5.3. Strategy
      • 30.2.5.4. Financial Performance

31. Global 3D Cell Culture Technologies Market Competitive Benchmarking

32. Global 3D Cell Culture Technologies Market Competitive Dashboard

33. Key Mergers And Acquisitions In The 3D Cell Culture Technologies Market

34. 3D Cell Culture Technologies Market Future Outlook and Potential Analysis

  • 34.1 3D Cell Culture Technologies Market In 2028 - Countries Offering Most New Opportunities
  • 34.2 3D Cell Culture Technologies Market In 2028 - Segments Offering Most New Opportunities
  • 34.3 3D Cell Culture Technologies Market In 2028 - Growth Strategies
  • 34.3.1 Market Trend Based Strategies
  • 34.3.2 Competitor Strategies

35. Appendix

  • 35.1. Abbreviations
  • 35.2. Currencies
  • 35.3. Historic And Forecast Inflation Rates
  • 35.4. Research Inquiries
  • 35.5. The Business Research Company
  • 35.6. Copyright And Disclaimer